FUS Mutations Alter Stress Granule Material Properties to Confer Autophagy Resistance

Target: FUS Composite Score: 0.613 Price: $0.61 Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Quality Report Card click to collapse
B
Composite: 0.613
Top 54% of 1166 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C+ Mech. Plausibility 15% 0.58 Top 65%
B Evidence Strength 15% 0.62 Top 45%
A Novelty 12% 0.82 Top 26%
B Feasibility 12% 0.60 Top 44%
B Impact 12% 0.65 Top 57%
C+ Druggability 10% 0.50 Top 63%
C+ Safety Profile 8% 0.55 Top 49%
B Competition 6% 0.68 Top 55%
C+ Data Availability 5% 0.58 Top 59%
C+ Reproducibility 5% 0.55 Top 60%
Evidence
3 supporting | 3 opposing
Citation quality: 0%
Debates
1 session B+
Avg quality: 0.75
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

How do pathological stress granules in neurodegeneration escape TRIM21/autophagy-mediated clearance?

The study shows TRIM21 and autophagy receptors can eliminate both physiological and pathological SGs, yet persistent stress granules are hallmarks of ALS/FTD. The mechanisms by which disease-associated SGs evade this clearance system remain unclear but are critical for therapeutic targeting. Gap type: open_question Source paper: Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3BP1 and autophagy-dependent elimination of stress granules. (2023, Autophagy, PMID:36692217)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

C9orf72 DPRs Impair Autophagy Receptor Docking on Stress Granules
Score: 0.717 | Target: C9orf72, p62/SQSTM1, OPTN
Differential Ubiquitin Chain Topology Creates 'Invisible' Surface on Pathological Stress Granules
Score: 0.682 | Target: TRIM21, G3BP1, OTUD1/OTUD7B
ALS-Linked OPTN/TBK1 Mutations Impair Phosphorylation Cascade Required for Pathological SG Recognition
Score: 0.648 | Target: OPTN, TBK1
ALS-Associated G3BP1/2 Mutations Disrupt TRIM21 Binding Interfaces
Score: 0.585 | Target: G3BP1, G3BP2
Hyperphosphorylated TDP-43 Traps TRIM21 Into Inactive Complexes
Score: 0.487 | Target: TARDBP, TRIM21
Casein Kinase 2 (CK2)-Mediated Hyperphosphorylation of G3BP1 Blocks TRIM21 Access
Score: 0.440 | Target: G3BP1, CSNK2A1 (CK2)

→ View full analysis & all 7 hypotheses

Description

ALS" class="entity-link entity-disease" title="disease: ALS">ALS-linked FUS mutations (P525L, R521C, R514S) alter phase separation properties, leading to stress granules with increased internal viscosity and delayed dynamics. Liquid-liquid phase separation dynamics critically determine whether stress granules can be recognized and engulfed by autophagosomes - more solidified granules may exceed size or compliance thresholds for autophagosomal capture despite adequate ubiquitination signals. This mechanism addresses how material properties influence clearance, a relatively novel therapeutic angle. Limitations include failure to distinguish correlation from causation and incomplete understanding of size thresholds for autophagosomal engulfment.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.58 (15%) Evidence 0.62 (15%) Novelty 0.82 (12%) Feasibility 0.60 (12%) Impact 0.65 (12%) Druggability 0.50 (10%) Safety 0.55 (8%) Competition 0.68 (6%) Data Avail. 0.58 (5%) Reproducible 0.55 (5%) 0.613 composite
6 citations 6 with PMID Validation: 0% 3 supporting / 3 opposing
For (3)
No supporting evidence
No opposing evidence
(3) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
2
2
2
MECH 2CLIN 2GENE 2EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
FUS mutations cause aberrant SG dynamics and incre…SupportingGENE----PMID:25437563-
FUS undergoes liquid-liquid phase separation and i…SupportingCLIN----PMID:26017149-
Modulating phase separation properties is emerging…SupportingCLIN----PMID:25891075-
Solidified SG states may be marker of pathology, n…OpposingMECH----PMID:29348140-
Autophagy receptors can handle gel-like substrates…OpposingMECH----PMID:29063990-
FUS mutations account for small fraction of ALS - …OpposingGENE----PMID:28424326-
Legacy Card View — expandable citation cards

Supporting Evidence 3

FUS mutations cause aberrant SG dynamics and increased aggregation
FUS undergoes liquid-liquid phase separation and is recruited to SGs
Modulating phase separation properties is emerging as therapeutic strategy

Opposing Evidence 3

Solidified SG states may be marker of pathology, not cause of clearance resistance
Autophagy receptors can handle gel-like substrates in other contexts (e.g., aggrephagy)
FUS mutations account for small fraction of ALS - mechanism not generalizable
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-22 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Mechanistic Hypotheses: Pathological Stress Granule Evasion of TRIM21/Autophagy Clearance

Hypothesis 1: G3BP1/2 Mutations Disrupt TRIM21 Binding Interfaces

Title: ALS-associated mutations in G3BP1/2 directly impair TRIM21-mediated ubiquitination and autophagy receptor recruitment

Mechanism:
Disease-associated mutations in G3BP1 (e.g., R378C, R382C/H) identified in ALS and amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) spectrum disorders may disrupt the TRIM21 recognition motif or alter protein conformation to prevent ubiquitination. G3BP1/2 serve as maste

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Pathological Stress Granule Evasion Hypotheses

Hypothesis 1: G3BP1/2 Mutations Disrupt TRIM21 Binding Interfaces

  • Binding site assumption unverified: The R378C/R382C mutations are located in G3BP1's RRM2 domain, yet the actual TRIM21 binding interface on G3BP1 has not been mapped. These mutations may not directly contact TRIM21—they could affect RNA binding or G3BP1 dimerization instead.
  • Precedent mismatch with established mechanisms: Mutations in glycine-arginine rich (RG) motifs typically enhance, not diminish, protein-protein inter
  • 🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

    Expert Feasibility Assessment: Pathological Stress Granule Evasion Mechanisms

    Preamble: Filtering the Hypothesis Space

    Of the seven hypotheses, five survive critical scrutiny with confidence scores ≥0.50. Two are deprioritized: H3 (TDP-43 sequestration of TRIM21) and H5 (CK2 hyperphosphorylation) fall below this threshold. H3 relies on unvalidated protein interactions and stoichiometric implausibility; H5 contradicts established literature showing CK2 phosphorylation promotes SG assembly rather than dissolution. The five surviving hypotheses are assessed below across druggabil

    Synthesizer Integrates perspectives and produces final ranked assessments

    {"ranked_hypotheses":[{"title":"C9orf72 DPRs Impair Autophagy Receptor Docking on Stress Granules","description":"Hexanucleotide repeat expansions in C9orf72 generate toxic dipeptide repeat proteins (poly-GR, poly-PR, poly-GA) that sterically occlude ubiquitin-binding domains of p62/SQSTM1 and OPTN, preventing autophagy receptor recruitment to ubiquitinated stress granules. This mechanism accounts for the most common genetic cause of familial ALS/FTD (~40% of familial ALS, ~25% of familial FTD) and may apply to downstream pathways shared with sporadic disease. Existing ASO clinical trials targ

    Price History

    0.600.610.62 0.63 0.59 2026-04-222026-04-222026-04-22 Market PriceScoreevidencedebate 1 events
    7d Trend
    Stable
    7d Momentum
    ▲ 0.0%
    Volatility
    Low
    0.0000
    Events (7d)
    1

    Clinical Trials (5) Relevance: 50%

    0
    Active
    0
    Completed
    0
    Total Enrolled
    PHASE1
    Highest Phase
    Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau PHASE1
    NOT_YET_RECRUITING · NCT06600880 · Columbia University
    Alzheimer Disease, Early Onset
    Neuronavigation-guided single-element focused ultrasound transducer Lumason Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents
    ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease NA
    COMPLETED · NCT03739905 · InSightec
    Alzheimer Disease
    Blood Brain Barrier (BBB) Disruption
    Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound NA
    COMPLETED · NCT04118764 · Columbia University
    Alzheimer Disease
    Neuronavigation-guided single-element focused ultrasound transducer Definity Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents
    Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis Unknown
    RECRUITING · NCT06339190 · Monash University
    Neurodegenerative Diseases Dementia
    Venepuncture
    Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy EARLY_PHASE1
    ACTIVE_NOT_RECRUITING · NCT05469009 · Ali Rezai
    Mild Cognitive Impairment Alzheimer Disease 1
    Aducanumab Exablate Model 4000 Type 2 Lecanemab

    📚 Cited Papers (6)

    Paper:25437563
    No extracted figures yet
    Paper:25891075
    No extracted figures yet
    Paper:26017149
    No extracted figures yet
    Paper:28424326
    No extracted figures yet
    Paper:29063990
    No extracted figures yet
    Paper:29348140
    No extracted figures yet

    📓 Linked Notebooks (0)

    No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

    ⚔ Arena Performance

    No arena matches recorded yet. Browse Arenas
    → Browse all arenas & tournaments

    Related Hypotheses

    ASO-Mediated Exon Skipping to Restore FUS-TAZ Chaperone Axis
    Score: 0.720 | neurodegeneration
    FUS Mutations Impede G3BP1's Chaperone Function, Exposing Neurotoxic Stress Granule Intermediates
    Score: 0.430 | neurodegeneration
    TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
    Score: 0.990 | neurodegeneration
    LRP1-Dependent Tau Uptake Disruption
    Score: 0.979 | neurodegeneration
    Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome
    Score: 0.975 | neurodegeneration

    Estimated Development

    Estimated Cost
    $0
    Timeline
    0 months

    🧪 Falsifiable Predictions

    No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

    Knowledge Subgraph (0 edges)

    No knowledge graph edges recorded

    3D Protein Structure

    🧬 FUS — PDB 4FDD Click to expand 3D viewer

    Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

    Source Analysis

    How do pathological stress granules in neurodegeneration escape TRIM21/autophagy-mediated clearance?

    neurodegeneration | 2026-04-06 | archived

    Community Feedback

    0 0 upvotes · 0 downvotes
    💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

    No comments yet. Be the first to comment!

    View all feedback (JSON)